Results 1 to 10 of about 1,502,037 (222)

Yttrium-90 radiation segmentectomy of oligometastatic urothelial carcinoma [PDF]

open access: yesRadiology Case Reports
Many patients with primary or metastatic liver tumors are not surgical candidates or have lesions that are not amenable to thermal ablation. Radiation segmentectomy involves microcatheter delivery of an ablative dose of Yttrium-90 microspheres through ...
Andrew E. Warfield, PhD   +5 more
doaj   +2 more sources

Single-system outcomes after adopting yttrium-90 radioembolization with personalized dosimetry as the primary treatment approach for unresectable, solitary hepatocellular carcinoma [PDF]

open access: yesESMO Gastrointestinal Oncology
Background: Yittrium-90 (90Y) radioembolization has emerged as a secondary treatment option for early- to intermediate-stage hepatocellular carcinoma (HCC) in the Barcelona Clinic Liver Cancer (BCLC) Staging and Treatment Algorithm.
A. Zamani   +5 more
doaj   +2 more sources

Yttrium-90 radioembolization for primary and metastatic liver tumors exhibiting arterial-phase hypovascularity [PDF]

open access: yesScientific Reports
To investigate dosimetry-derived tumor-to-perfused normal tissue ratio (T/N) and corresponding clinical outcomes of patients receiving yttrium-90 radioembolization with glass microspheres for tumors identified as hypovascular on arterial-phase cross ...
Mira Malavia   +8 more
doaj   +2 more sources

Rapid 90Sr quantification method based on the Bateman equation for routine laboratory work

open access: yesNukleonika, 2022
Artificially introduced into the environment 90Sr is highly radiotoxic, so its content levels in foodstuff and biota require constant monitoring for radiological protection.
Wiatr Karol   +2 more
doaj   +1 more source

Comparison of the Biograph Vision and Biograph mCT for quantitative 90Y PET/CT imaging for radioembolisation

open access: yesEJNMMI Physics, 2020
Background New digital PET scanners with improved time of flight timing and extended axial field of view such as the Siemens Biograph Vision have come on the market and are expected to replace current generation photomultiplier tube (PMT)-based systems ...
Britt Kunnen   +4 more
doaj   +1 more source

Concepts and methods for the dosimetry of radioembolisation of the liver with Y-90-loaded microspheres

open access: yesFrontiers in Nuclear Medicine, 2022
This article aims at presenting in a didactic way, dosimetry concepts and methods that are relevant for radio-embolization of the liver with 90Y-microspheres.
Arnaud Dieudonné   +4 more
doaj   +1 more source

A Comparison of Techniques for 90Y PET/CT Image-Based Dosimetry following Radioembolization with Resin Microspheres

open access: yesFrontiers in Oncology, 2014
90Y PET/CT following radioembolization has recently been established as a viable diagnostic tool, capable of producing images that are both quantitative and have superior image quality than alternative 90Y imaging modalities.
Alexander Samuel Pasciak   +3 more
doaj   +1 more source

Single-Compartment Dose Prescriptions for Ablative 90Y-Radioembolization Segmentectomy

open access: yesLife, 2023
Background: Yttrium-90 (90Y) radioembolization is increasingly being utilized with curative intent. While single-compartment doses with respect to the perfused volume for the complete pathologic necrosis (CPN) of tumors have been reported, the actual ...
Srinivas Cheenu Kappadath   +1 more
doaj   +1 more source

Application of Ion-Exchange Resin Column for Basic Development of Strontium-90/Yttrium-90 Generator for Preparation of Radiopharmaceutical Therapy

open access: yesIndonesian Journal of Chemistry, 2017
The aim of this study is to examine the possible use of ion-exchange resin on Dowex AG 50x8 in separating Y-90 from Sr-90 which then could be applied in the basic of manufacture of producing Sr-90/Y-90 generator for the production of radiopharmaceutical ...
Muchtaridi Muchtaridi   +3 more
doaj   +1 more source

Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of safety and feasibility

open access: yesJournal of Interventional Medicine, 2023
Purpose: The IMbrave150 Phase III trial demonstrated the superiority of atezolizumab and bevacizumab (Atezo/Bev) over sorafenib for unresectable hepatocellular carcinoma (HCC).
Qian Yu   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy